These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 27225239

  • 21. Impact of pneumococcal conjugate vaccines on childhood otitis media in the United Kingdom.
    Lau WC, Murray M, El-Turki A, Saxena S, Ladhani S, Long P, Sharland M, Wong IC, Hsia Y.
    Vaccine; 2015 Sep 22; 33(39):5072-9. PubMed ID: 26297875
    [Abstract] [Full Text] [Related]

  • 22. Streptococcus pneumoniae as cause of acute otitis media (AOM) in Slovak children in the pneumococcal conjugate vaccine era (2008-2019).
    Macaj M, Perdochova L, Jakubikova J.
    Vaccine; 2023 Jan 09; 41(2):452-459. PubMed ID: 36470684
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children <5 years: an active prospective nationwide surveillance.
    Ben-Shimol S, Greenberg D, Givon-Lavi N, Schlesinger Y, Somekh E, Aviner S, Miron D, Dagan R.
    Vaccine; 2014 Jun 05; 32(27):3452-9. PubMed ID: 24690148
    [Abstract] [Full Text] [Related]

  • 25. Pneumococcal conjugate vaccines for preventing acute otitis media in children.
    Fortanier AC, Venekamp RP, Boonacker CW, Hak E, Schilder AG, Sanders EA, Damoiseaux RA.
    Cochrane Database Syst Rev; 2019 May 28; 5(5):CD001480. PubMed ID: 31135969
    [Abstract] [Full Text] [Related]

  • 26. Potential contribution by nontypable Haemophilus influenzae in protracted and recurrent acute otitis media.
    Barkai G, Leibovitz E, Givon-Lavi N, Dagan R.
    Pediatr Infect Dis J; 2009 Jun 28; 28(6):466-71. PubMed ID: 19504729
    [Abstract] [Full Text] [Related]

  • 27. Changes in Otitis Media Episodes and Pressure Equalization Tube Insertions Among Young Children Following Introduction of the 13-Valent Pneumococcal Conjugate Vaccine: A Birth Cohort-based Study.
    Wiese AD, Huang X, Yu C, Mitchel EF, Kyaw MH, Griffin MR, Grijalva CG.
    Clin Infect Dis; 2019 Nov 27; 69(12):2162-2169. PubMed ID: 30770533
    [Abstract] [Full Text] [Related]

  • 28. Evolving microbiology of complicated acute otitis media before and after introduction of the pneumococcal conjugate vaccine in France.
    Dupont D, Mahjoub-Messai F, François M, Doit C, Mariani-Kurkdjian P, Bidet P, Bonacorsi S, Carol A, Bingen E.
    Diagn Microbiol Infect Dis; 2010 Sep 27; 68(1):89-92. PubMed ID: 20727478
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Epidemiology of Streptococcus pneumoniae causing acute otitis media among children in Southern Catalonia throughout 2007-2013: Incidence, serotype distribution and vaccine's effectiveness.
    Ochoa-Gondar O, Figuerola-Massana E, Vila-Corcoles A, Aguirre CA, de Diego C, Satue E, Gomez F, Raga X, EPIVAC Study Group.
    Int J Pediatr Otorhinolaryngol; 2015 Dec 27; 79(12):2104-8. PubMed ID: 26453272
    [Abstract] [Full Text] [Related]

  • 31. Interaction With Nontypeable Haemophilus influenzae Alters Progression of Streptococcus pneumoniae From Colonization to Disease in a Site-Specific Manner.
    Lewnard JA, Givon-Lavi N, Dagan R.
    J Infect Dis; 2019 Sep 13; 220(8):1367-1376. PubMed ID: 31233130
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Dynamics of Severe and Non-severe Invasive Pneumococcal Disease in Young Children in Israel Following PCV7/PCV13 Introduction.
    Glikman D, Dagan R, Barkai G, Averbuch D, Guri A, Givon-Lavi N, Ben-Shimol S, Israel Bacteremia and Meningitis Active Surveillance Group.
    Pediatr Infect Dis J; 2018 Oct 13; 37(10):1048-1053. PubMed ID: 29750768
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A 13-year survey of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 and PCV13 implementation.
    Cohen R, Varon E, Doit C, Schlemmer C, Romain O, Thollot F, Béchet S, Bonacorsi S, Levy C.
    Vaccine; 2015 Sep 22; 33(39):5118-26. PubMed ID: 26271823
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Changing trends of acute otitis media bacteriology in central Israel in the pneumococcal conjugate vaccines era.
    Tamir SO, Roth Y, Dalal I, Goldfarb A, Grotto I, Marom T.
    Pediatr Infect Dis J; 2015 Feb 22; 34(2):195-9. PubMed ID: 25741972
    [Abstract] [Full Text] [Related]

  • 38. Pneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern Israel.
    Ben-Shimol S, Givon-Lavi N, Greenberg D, Dagan R.
    Hum Vaccin Immunother; 2016 Feb 22; 12(2):268-76. PubMed ID: 26430921
    [Abstract] [Full Text] [Related]

  • 39. Bacterial etiology of acute otitis media in the era prior to universal pneumococcal vaccination in Taiwanese children.
    Kung YH, Chiu NC, Lee KS, Chang L, Huang DT, Huang FY, Hsieh YC, Huang LM, Chi H.
    J Microbiol Immunol Infect; 2014 Jun 22; 47(3):239-44. PubMed ID: 24080520
    [Abstract] [Full Text] [Related]

  • 40. Impact of pneumococcal conjugate vaccines on microbial epidemiology and clinical outcomes of acute otitis media.
    Hau I, Levy C, Caeymaex L, Cohen R.
    Paediatr Drugs; 2014 Feb 22; 16(1):1-12. PubMed ID: 23963858
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.